HIV-1 genotyping of the protease-reverse transcriptase and integrase genes to detect mutations that confer antiretroviral resistance

Methods in Molecular Biology

Volumn 1030, Issue , 2013, Pages 37-55

  Van Den Eede, Peter ^a   Van Wesenbeeck, Liesbeth ^a   Verlinden, Yvan ^a   Feyaerts, Maxim ^a   Smits, Veerle ^a   Verheyen, Ann ^a   Vanhooren, Leen ^a   Deloof, Alain ^a   Villacian, Jorge ^a   Pattery, Theresa ^a  

^a JANSSEN RESEARCH FOUNDATION   (Belgium)

Author keywords

Genotyping; HIV 1; Integrase inhibitors; Protease inhibitors; Resistance testing; Resistance associated mutations; Reverse transcriptase inhibitors; vircoTYPE HIV 1

Indexed keywords

DEOXYRIBONUCLEASE; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE; INTEGRASE; INTEGRASE INHIBITOR; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RIBONUCLEASE; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA;

AMINO ACID SEQUENCE; AMPLICON; ANTIVIRAL RESISTANCE; ARTICLE; CAPILLARY ELECTROPHORESIS; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC RESISTANCE; GENOTYPING TECHNIQUE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; SEQUENCE ANALYSIS; VIRUS GENE;

COMPUTATIONAL BIOLOGY; DRUG RESISTANCE, VIRAL; GENOTYPE; GENOTYPING TECHNIQUES; HIV INTEGRASE; HIV PROTEASE; HIV REVERSE TRANSCRIPTASE; HIV-1; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SEQUENCE ANALYSIS, DNA;

EID: 84880088164     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-484-5_5     Document Type: Article

References (9)

1. Zolopa AR (2010) The evolution of HIV treatment guidelines: current state-of-the-art of ART. Antiviral Res 85(1):241-244
2. Stewart A, Chan Carusone S, To K et al (2012) Causes of death in HIV patients and the evolution of an AIDS hospice: 1988-2008. AIDS Res Treat 2012:390406
3. Lengauer T (2012) Bioinformatical assistance of selecting anti-HIV therapies: where do we stand? Intervirology 55:108-122
4. U.S. Department of Health and Human Services (2012) Panel on Antiretroviral Guidelines for Adults and Adolescents-A Working Group of the Offi ce of AIDS Research Advisory Council (OARAC). http://aidsinfo.nih.gov/ guidelines/html/1/adult-and-adolescent-treatmentguidelines/0/
5. EACS guidelines (2011) European Guidelines for treatment of HIV infected adults in Europe http://www.europeanaidsclinicalsociety.org/index.php?option= com-content&view=article&id=59&Itemid=41
6. Frentz D, Boucher CA, Assel M et al (2010) Comparison of HIV-1 genotypic resistance test interpretation systems in predicting virological outcomes over time. PLoS One 5(7): e11505
7. Pattery T, Verlinden Y, De Wolf H et al (2012) Development and performance of conventional HIV-1 phenotyping (Antivirogram ) and genotype-based calculated phenotyping assay (virco TYPE HIV-1) on protease and reverse transcriptase genes to evaluate drug resistance. Intervirology 55(2):138-146
8. Van Houtte M, Picchio G, Van Der Borght K et al (2009) A comparison of HIV-1 drug susceptibility as provided by conventional phenotyping and by a phenotype prediction tool based on viral genotype. J Med Virol 81(10):1702-1709
9. Zazzi M, Incardona F, Rosen-zvi M et al (2012) Predicting response to antiretroviral treatment by machine learning: the EuResist project. Intervirology 55:123-127